Pharmacokinetics of valproic acid in young and elderly subjects

British Journal of Clinical Pharmacology
S M BrysonP C Rubin

Abstract

The disposition of valproic acid was studied following single dose intravenous administration in seven young male volunteers aged 20-35 years and six elderly male in-patients aged 75-87 years. Following administration of 400 mg sodium valproate, blood samples were collected for 48 h and valproic acid concentrations analysed by enzymatic immunoassay. The median elimination half-life was 7.2 h in the young subjects but 14.9 h in the elderly patients (P less than 0.01). However, clearance did not differ significantly between groups, the values for young and old being 0.69 and 0.58 1/h respectively. The prolonged half-life resulted from a greater volume of distribution in the elderly. The median values (1/kg) for young and old were 0.13 and 0.19 respectively (P less than 0.01). These pharmacokinetic changes are unlikely to be of clinical importance.

References

Jan 1, 1980·Clinical Pharmacokinetics·R Gugler, G E von Unruh
May 6, 1982·The New England Journal of Medicine·D J GreenblattR I Shader
Feb 1, 1982·British Journal of Clinical Pharmacology·P C RubinJ L Reid
Sep 1, 1981·British Journal of Clinical Pharmacology·P C RubinJ L Reid

❮ Previous
Next ❯

Citations

Mar 20, 2002·Current Neurology and Neuroscience Reports·I E Leppik
Jan 1, 1988·Pharmacology & Therapeutics·J Roberts, N Tumer
Apr 1, 1986·Clinical Biochemistry·P A Mitenko
May 21, 1998·Pharmacology & Therapeutics·L J Willmore
Jun 25, 1999·Progress in Neurobiology·P GareriG De Sarro
Dec 11, 2002·Journal of Clinical Pharmacy and Therapeutics·H-M ParkD-S Yim
Jun 1, 1994·British Journal of Clinical Pharmacology·G D AndersonH R Winn
Jan 1, 1996·Epilepsia·L J Willmore
Apr 11, 2008·Clinical Pharmacokinetics·Jennifer M Butler, Evan J Begg
Jul 11, 2014·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Kayode OgungbenroUNKNOWN CRESim & Epi-CRESim Project Groups
Mar 16, 2006·Drug Development and Industrial Pharmacy·Yuki FujisakiKenji Sugibayashi
Apr 14, 2006·Expert Opinion on Drug Safety·Howard H FennBrian Alldredge
Feb 14, 2007·The American Journal of Geriatric Pharmacotherapy·Rehan AzizRajesh R Tampi
Dec 6, 2005·The Psychiatric Clinics of North America·Robert C Young
Jun 15, 2005·Bipolar Disorders·Lakshmi N YathamUNKNOWN Canadian Network for Mood and Anxiety Treatments
Dec 8, 2004·Epilepsy Research·Angela K BirnbaumIlo E Leppik
Jun 1, 1984·British Journal of Clinical Pharmacology·E PeruccaG M Frigo
Aug 9, 2016·Journal of Pharmaceutical Sciences·Hirokazu KatayamaTomomi Hatae
Oct 2, 2003·Journal of Clinical Psychopharmacology·Susy FelixClaudio A Naranjo
Mar 20, 2002·Pharmacotherapy·Thomas E Lackner
Jul 1, 1993·Biopharmaceutics & Drug Disposition·Z HusseinG R Granneman
Feb 12, 2010·Annals of the New York Academy of Sciences·Ilo E Leppik, Angela K Birnbaum
Dec 12, 2001·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·S Arroyo, G Kramer
Jan 1, 1992·Critical Reviews in Toxicology·E Nelson
Sep 28, 2007·Therapeutic Drug Monitoring·Angela K BirnbaumIlo E Leppik
May 1, 1985·Pharmacotherapy·E M Rimmer, A Richens
Aug 8, 2020·Expert Opinion on Drug Metabolism & Toxicology·Roberta RobertiRita Citraro

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved